{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:17:20Z","timestamp":1782166640618,"version":"3.54.5"},"reference-count":179,"publisher":"Elsevier","isbn-type":[{"value":"9780128177501","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.apcsb.2019.08.003","type":"book-chapter","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T03:08:45Z","timestamp":1578020925000},"page":"371-411","source":"Crossref","is-referenced-by-count":7,"title":["Misfolded proteins as a therapeutic target in Alzheimer's disease"],"prefix":"10.1016","member":"78","reference":[{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10522-017-9710-z","article-title":"Lipid (per) oxidation in mitochondria: An emerging target in the ageing process?","volume":"18","author":"Ademowo","year":"2017","journal-title":"Biogerontology"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3233\/JAD-170662","article-title":"Metals and Alzheimer's disease: How far have we come in the clinic?","volume":"62","author":"Adlard","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"12","key":"10.1016\/bs.apcsb.2019.08.003_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00023210-200519120-00002","article-title":"The development of anti-amyloid therapy for Alzheimer's disease : From secretase modulators to polymerisation inhibitors","volume":"19","author":"Aisen","year":"2005","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/bs.apcsb.2019.08.003_bib4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.0b013e3181b7849b","article-title":"Leisure activities and the risk of dementia in the elderly: Results from the three-city study","volume":"73","author":"Akbaraly","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer's Association","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: Review and meta-analysis","volume":"56","author":"Anstey","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib7","doi-asserted-by":"crossref","first-page":"134971","DOI":"10.4061\/2011\/134971","article-title":"Impacts of membrane biophysics in Alzheimer's disease: From amyloid precursor protein processing to abeta peptide-induced membrane changes","volume":"2011","author":"Askarova","year":"2011","journal-title":"International Journal of Alzheimer's Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000337231","article-title":"A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier","volume":"11","author":"Bachmeier","year":"2013","journal-title":"Neurodegenerative Diseases"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib9","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"21","key":"10.1016\/bs.apcsb.2019.08.003_bib10","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1021\/jm301079z","article-title":"Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies","volume":"55","author":"Ballatore","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1567205012666141218140953","article-title":"Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease","volume":"12","author":"Baranello","year":"2015","journal-title":"Current Alzheimer Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.mp.4000552","article-title":"It all sticks together--the APP-related family of proteins and Alzheimer's disease","volume":"4","author":"Bayer","year":"1999","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbalip.2010.03.008","article-title":"Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?","volume":"1801","author":"Beel","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"14","key":"10.1016\/bs.apcsb.2019.08.003_bib14","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2174\/1381612043384664","article-title":"Oxygen, reactive oxygen species and tissue damage","volume":"10","author":"Bergamini","year":"2004","journal-title":"Current Pharmaceutical Design"},{"issue":"11","key":"10.1016\/bs.apcsb.2019.08.003_bib15","first-page":"985","article-title":"RAGE in inflammation: A new therapeutic target?","volume":"7","author":"Bierhaus","year":"2006","journal-title":"Current Opinion in Investigational Drugs"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1074\/jbc.M116.762526","article-title":"Ion channel formation by amyloid-beta42 oligomers but not amyloid-beta40 in cellular membranes","volume":"292","author":"Bode","year":"2017","journal-title":"Journal of Biological Chemistry"},{"issue":"19","key":"10.1016\/bs.apcsb.2019.08.003_bib17","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1074\/jbc.AC118.007195","article-title":"Amyloid-beta oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy","volume":"294","author":"Bode","year":"2019","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-510X(98)00128-2","article-title":"History of dementia and dementia in history: An overview","volume":"158","author":"Boller","year":"1998","journal-title":"Journal of Neurological Sciences"},{"issue":"9\u201310","key":"10.1016\/bs.apcsb.2019.08.003_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer's disease: Past, present, and future","volume":"23","author":"Bondi","year":"2017","journal-title":"Journal of the International Neuropsychological Society"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnins.2018.00330","article-title":"Sleep disorders associated with Alzheimer's disease: A perspective","volume":"12","author":"Brzecka","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2019.08.003_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2008.01.014","article-title":"Somatostatin and Alzheimer's disease","volume":"286","author":"Burgos-Ramos","year":"2008","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"3\u20134","key":"10.1016\/bs.apcsb.2019.08.003_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnins.2018.00163","article-title":"The association of tau with mitochondrial dysfunction in Alzheimer's disease","volume":"12","author":"Cheng","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib24","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis","volume":"8","author":"Chu","year":"2018","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2010.02.001","article-title":"Size-dependent neurotoxicity of beta-amyloid oligomers","volume":"496","author":"Cizas","year":"2010","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"24","key":"10.1016\/bs.apcsb.2019.08.003_bib26","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer's disease drug development pipeline: 2018","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: Few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Research & Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer's disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS & Neurological Disorders \u2013 Drug Targets"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990\u20132016: A systematic analysis for the global burden of disease study 2016","volume":"18","author":"Dementia Collaborators","year":"2019","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2018.00267","article-title":"Synaptic tau seeding precedes tau pathology in human Alzheimer's disease brain","volume":"12","author":"DeVos","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib33","doi-asserted-by":"crossref","first-page":"1245049","DOI":"10.1155\/2016\/1245049","article-title":"Role of ROS and RNS sources in physiological and pathological conditions","volume":"2016","author":"Di Meo","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","article-title":"Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease","volume":"67","author":"Donahue","year":"2008","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"11\u201312","key":"10.1016\/bs.apcsb.2019.08.003_bib35","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1111\/j.1582-4934.2009.00889.x","article-title":"Neuronal death in Alzheimer's disease and therapeutic opportunities","volume":"13","author":"Donev","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3233\/JAD-161143","article-title":"Cortical iron reflects severity of Alzheimer's disease","volume":"60","author":"van Duijn","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Translational Neurodegeneration"},{"issue":"27","key":"10.1016\/bs.apcsb.2019.08.003_bib39","doi-asserted-by":"crossref","first-page":"24540","DOI":"10.1074\/jbc.M007579200","article-title":"Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme","volume":"276","author":"Eckman","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000341273.18141.64","article-title":"Factors associated with resistance to dementia despite high Alzheimer disease pathology","volume":"72","author":"Erten-Lyons","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt105","article-title":"Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease","volume":"4","author":"Esiri","year":"2012","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib42","doi-asserted-by":"crossref","first-page":"38187","DOI":"10.1038\/srep38187","article-title":"Soluble amyloid-beta aggregates from human Alzheimer's disease brains","volume":"6","author":"Esparza","year":"2016","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","article-title":"Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases","volume":"92","author":"Espay","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib44","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib45","first-page":"245","article-title":"Hippocampal injections of oligomeric amyloid beta-peptide (1-42) induce selective working memory deficits and long-lasting alterations of ERK signaling pathway","volume":"7","author":"Faucher","year":"2015","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"10","key":"10.1016\/bs.apcsb.2019.08.003_bib46","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/138161282210160304111702","article-title":"Membrane damage induced by amyloid beta and a potential link with neuroinflammation","volume":"22","author":"Fernandez-Perez","year":"2016","journal-title":"Current Pharmaceutical Design"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","article-title":"Head injury as a risk factor for Alzheimer's disease: The evidence 10 years on; a partial replication","volume":"74","author":"Fleminger","year":"2003","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/prot.20683","article-title":"Misfolding of the amyloid beta-protein: A molecular dynamics study","volume":"62","author":"Flock","year":"2006","journal-title":"Proteins"},{"issue":"17","key":"10.1016\/bs.apcsb.2019.08.003_bib49","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.0000000000000364","article-title":"Clinical trial of an inhibitor of RAGE-Abeta interactions in Alzheimer disease","volume":"82","author":"Galasko","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib50","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archneur.62.5.779","article-title":"Alzheimer disease and mortality: A 15-year epidemiological study","volume":"62","author":"Ganguli","year":"2005","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/lm.1310209","article-title":"Amyloid beta mediates memory formation","volume":"16","author":"Garcia-Osta","year":"2009","journal-title":"Learning & Memory"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JAD-150765","article-title":"Diet and inflammation in Alzheimer's disease and related chronic diseases: A review","volume":"50","author":"Gardener","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2\u20133","key":"10.1016\/bs.apcsb.2019.08.003_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000101848","article-title":"Frontotemporal dementia with tau pathology","volume":"4","author":"Gasparini","year":"2007","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fneur.2013.00093","article-title":"Formation and propagation of tau oligomeric seeds","volume":"4","author":"Gerson","year":"2013","journal-title":"Frontiers in Neurology"},{"issue":"19","key":"10.1016\/bs.apcsb.2019.08.003_bib55","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chemical Society Reviews"},{"issue":"9","key":"10.1016\/bs.apcsb.2019.08.003_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092677","article-title":"Targeting amyloid aggregation: An overview of strategies and mechanisms","volume":"19","author":"Giorgetti","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"13","key":"10.1016\/bs.apcsb.2019.08.003_bib57","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","article-title":"Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization","volume":"9","author":"Goedert","year":"1990","journal-title":"The EMBO Journal"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib58","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1073\/pnas.89.5.1983","article-title":"Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system","volume":"89","author":"Goedert","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib59","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3233\/JAD-171133","article-title":"Alzheimer's amyloid-beta is an antimicrobial peptide: A review of the evidence","volume":"62","author":"Gosztyla","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","article-title":"Metal dyshomeostasis and oxidative stress in Alzheimer's disease","volume":"62","author":"Greenough","year":"2013","journal-title":"Neurochemistry International"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0896-6273(01)00496-2","article-title":"Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila","volume":"32","author":"Gunawardena","year":"2001","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41557-018-0031-x","article-title":"Cholesterol catalyses Abeta42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes","volume":"10","author":"Habchi","year":"2018","journal-title":"Nature Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.mehy.2005.02.045","article-title":"Etiology of sporadic Alzheimer's disease: Somatostatin, neprilysin, and amyloid beta peptide","volume":"65","author":"Hama","year":"2005","journal-title":"Medical Hypotheses"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/biom4010101","article-title":"Effect of metals on kinetic pathways of amyloid-beta aggregation","volume":"4","author":"Hane","year":"2014","journal-title":"Biomolecules"},{"issue":"19","key":"10.1016\/bs.apcsb.2019.08.003_bib65","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/01.wnl.0000334278.11022.42","article-title":"Survival in Alzheimer disease: A multiethnic, population-based study of incident cases","volume":"71","author":"Helzner","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/156720508783954703","article-title":"Neprilysin and amyloid beta peptide degradation","volume":"5","author":"Hersh","year":"2008","journal-title":"Current Alzheimer Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib67","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2016.06.009","article-title":"Alzheimer disease and its growing epidemic: Risk factors, biomarkers, and the urgent need for therapeutics","volume":"34","author":"Hickman","year":"2016","journal-title":"Neurologic Clinics"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib68","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.410350514","article-title":"Transgenic mouse brain histopathology resembles early Alzheimer's disease","volume":"35","author":"Higgins","year":"1994","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib69","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9440(10)63462-1","article-title":"Nitration of tau protein is linked to neurodegeneration in tauopathies","volume":"163","author":"Horiguchi","year":"2003","journal-title":"American Journal Of Pathology"},{"issue":"11","key":"10.1016\/bs.apcsb.2019.08.003_bib70","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.molmed.2011.06.002","article-title":"Presenilins in synaptic function and disease","volume":"17","author":"Ho","year":"2011","journal-title":"Trends in Molecular Medicine"},{"issue":"9","key":"10.1016\/bs.apcsb.2019.08.003_bib71","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/0929867323666160229113911","article-title":"Amyloid beta (abeta) peptide and factors that play important roles in Alzheimer's disease","volume":"23","author":"Jamasbi","year":"2016","journal-title":"Current Medicinal Chemistry"},{"issue":"40","key":"10.1016\/bs.apcsb.2019.08.003_bib72","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/bi800783d","article-title":"The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments","volume":"47","author":"Jeganathan","year":"2008","journal-title":"Biochemistry"},{"issue":"Pt 24","key":"10.1016\/bs.apcsb.2019.08.003_bib73","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"Journal of Cell Science"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2019.08.003_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12031-009-9237-0","article-title":"Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease","volume":"40","author":"Jurgensen","year":"2010","journal-title":"Journal of Molecular Neuroscience"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib75","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib77","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(03)00898-X","article-title":"Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form","volume":"350","author":"Kanemitsu","year":"2003","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib78","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.devcel.2015.01.022","article-title":"Cellular functions of the amyloid precursor protein from development to dementia","volume":"32","author":"van der Kant","year":"2015","journal-title":"Developmental Cell"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1189\/jlb.1012519","article-title":"RAGE regulation and signaling in inflammation and beyond","volume":"94","author":"Kierdorf","year":"2013","journal-title":"Journal of Leukocyte Biology"},{"issue":"43","key":"10.1016\/bs.apcsb.2019.08.003_bib80","doi-asserted-by":"crossref","first-page":"15824","DOI":"10.1073\/pnas.0605629103","article-title":"Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide","volume":"103","author":"Kim","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"109","key":"10.1016\/bs.apcsb.2019.08.003_bib81","doi-asserted-by":"crossref","DOI":"10.3791\/53308","article-title":"Intracerebroventricular injection of amyloid-beta peptides in normal mice to acutely induce Alzheimer-like cognitive deficits","author":"Kim","year":"2016","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib82","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib83","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2174\/138161212799315786","article-title":"Transgenic mouse models of Alzheimer disease: Developing a better model as a tool for therapeutic interventions","volume":"18","author":"Kitazawa","year":"2012","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib84","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ssmph.2016.06.002","article-title":"Does multilingualism affect the incidence of Alzheimer's disease?: A worldwide analysis by country","volume":"2","author":"Klein","year":"2016","journal-title":"SSM Popul Health"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","article-title":"Soluble forms of tau are toxic in Alzheimer's disease","volume":"3","author":"Kopeikina","year":"2012","journal-title":"Translational Neuroscience"},{"issue":"340","key":"10.1016\/bs.apcsb.2019.08.003_bib86","doi-asserted-by":"crossref","first-page":"340ra372","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib87","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.bbamem.2007.04.021","article-title":"Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm","volume":"1768","author":"Lal","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib88","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1471-4159.2005.03497.x","article-title":"Biophysical characterization of longer forms of amyloid beta peptides: Possible contribution to flocculent plaque formation","volume":"95","author":"Lambermon","year":"2005","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib89","doi-asserted-by":"crossref","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoiselee","year":"2017","journal-title":"PLoS Medicine"},{"issue":"13","key":"10.1016\/bs.apcsb.2019.08.003_bib90","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1039\/C7CP05072K","article-title":"Metal ions affect the formation and stability of amyloid beta aggregates at multiple length scales","volume":"20","author":"Lee","year":"2018","journal-title":"Physical Chemistry Chemical Physics"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"Journal of Neural Transmission"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib92","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12017-013-8257-7","article-title":"SUMO and Alzheimer's disease","volume":"15","author":"Lee","year":"2013","journal-title":"NeuroMolecular Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ab.2006.04.036","article-title":"Biotin-avidin interaction-based screening assay for Alzheimer's beta-peptide oligomer inhibitors","volume":"356","author":"LeVine","year":"2006","journal-title":"Analytical Biochemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bpj.2011.12.002","article-title":"Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer","volume":"102","author":"Lin","year":"2012","journal-title":"Biophysical Journal"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(10)70065-X","article-title":"Early prognosis in traumatic brain injury: From prophecies to predictions","volume":"9","author":"Lingsma","year":"2010","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib96","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.trci.2018.09.003","article-title":"The hidden variables problem in Alzheimer's disease clinical trial design","volume":"4","author":"Liyanage","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib97","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fnagi.2017.00300","article-title":"Serum copper, zinc, and iron levels in patients with Alzheimer's disease: A meta-analysis of case-control studies","volume":"9","author":"Li","year":"2017","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"Journal of Neurological Sciences"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib99","article-title":"Role of tau acetylation in Alzheimer's disease and chronic traumatic encephalopathy: The way forward for successful treatment","volume":"4","author":"Lucke-Wold","year":"2017","journal-title":"Journal of Neurology, Neurosurgery"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13670-011-0004-z","article-title":"Animal models of Alzheimer's disease: Utilization of transgenic Alzheimer's disease models in studies of amyloid beta clearance","volume":"1","author":"Malm","year":"2012","journal-title":"Current Translational Geriatrics and Gerontology Reports"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib101","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"28","key":"10.1016\/bs.apcsb.2019.08.003_bib102","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.1073\/pnas.1604299113","article-title":"Physiological role for amyloid precursor protein in adult experience-dependent plasticity","volume":"113","author":"Marik","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2019.08.003_bib103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1385\/JMN:22:1-2:5","article-title":"Neprilysin regulates amyloid Beta peptide levels","volume":"22","author":"Marr","year":"2004","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib104","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fnins.2018.00963","article-title":"Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer's disease","volume":"12","author":"Marttinen","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"Suppl. 1","key":"10.1016\/bs.apcsb.2019.08.003_bib105","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/alzrt197","article-title":"Early-onset dementias: Diagnostic and etiological considerations","volume":"5","author":"Masellis","year":"2013","journal-title":"Alzheimer's Research & Therapy"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.0959-9673.2005.00434.x","article-title":"Metals and amyloid-beta in Alzheimer's disease","volume":"86","author":"Maynard","year":"2005","journal-title":"International Journal of Experimental Pathology"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib107","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ncl.2017.01.005","article-title":"Early-onset Alzheimer disease","volume":"35","author":"Mendez","year":"2017","journal-title":"Neurologic Clinics"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib108","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001199-200108000-00005","article-title":"Long-term neuropsychological outcome after traumatic brain injury","volume":"16","author":"Millis","year":"2001","journal-title":"The Journal of Head Trauma Rehabilitation"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib109","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease","volume":"2","author":"Morris","year":"2014","journal-title":"Acta Neuropathologica Communications"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib110","doi-asserted-by":"crossref","first-page":"e0170547","DOI":"10.1371\/journal.pone.0170547","article-title":"Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial","volume":"12","author":"Morris","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.apcsb.2019.08.003_bib111","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/13543784.2017.1369527","article-title":"Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease","volume":"26","author":"Moussa","year":"2017","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib112","doi-asserted-by":"crossref","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid beta-protein: Synaptic and network dysfunction","volume":"2","author":"Mucke","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib113","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathologica Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib114","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.57.6.885","article-title":"Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene","volume":"57","author":"Murrell","year":"2000","journal-title":"Archives of Neurology"},{"issue":"23","key":"10.1016\/bs.apcsb.2019.08.003_bib116","doi-asserted-by":"crossref","first-page":"9191","DOI":"10.1073\/pnas.0810364106","article-title":"Alpha-helix targeting reduces amyloid-beta peptide toxicity","volume":"106","author":"Nerelius","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"9","key":"10.1016\/bs.apcsb.2019.08.003_bib117","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1152\/jn.00589.2011","article-title":"Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices","volume":"107","author":"Nomura","year":"2012","journal-title":"Journal of Neurophysiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib118","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12263-013-0379-x","article-title":"Zinc and the aging brain","volume":"9","author":"Nuttall","year":"2014","journal-title":"Genes Nutr"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annual Review of Neuroscience"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1582-4934.2008.00276.x","article-title":"The ubiquitin-proteasome system in Alzheimer's disease","volume":"12","author":"Oddo","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib121","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4067\/S0716-97602000000200012","article-title":"Amyloid-beta-peptide reduces copper (II) to copper (I) independent of its aggregation state","volume":"33","author":"Opazo","year":"2000","journal-title":"Biological Research"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib122","doi-asserted-by":"crossref","first-page":"22769","DOI":"10.1038\/srep22769","article-title":"Distinctive pattern of serum elements during the progression of Alzheimer's disease","volume":"6","author":"Paglia","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","article-title":"Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice","volume":"73","author":"Peeraer","year":"2015","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib124","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3233\/JAD-160275","article-title":"Pharmacological agents targeting gamma-secretase increase risk of cancer and cognitive decline in Alzheimer's disease patients: A systematic review and meta-analysis","volume":"53","author":"Penninkilampi","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbamem.2009.01.012","article-title":"The interaction of beta-amyloid protein with cellular membranes stimulates its own production","volume":"1788","author":"Peters","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer's Disease and aging","volume":"30","author":"Pini","year":"2016","journal-title":"Ageing Research Reviews"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib127","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbamem.2012.09.001","article-title":"How the amyloid-beta peptide and membranes affect each other: An extensive simulation study","volume":"1828","author":"Poojari","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib128","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00019052-199508000-00004","article-title":"Amyloid beta amyloidosis in Alzheimer's disease","volume":"8","author":"Price","year":"1995","journal-title":"Current Opinion in Neurology"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib130","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s004010050565","article-title":"Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment","volume":"92","author":"Probst","year":"1996","journal-title":"Acta Neuropathologica"},{"issue":"70","key":"10.1016\/bs.apcsb.2019.08.003_bib131","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1039\/C5CC05264E","article-title":"Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease","volume":"51","author":"Rajasekhar","year":"2015","journal-title":"Chemical Communications"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","article-title":"Traumatic brain injury and Alzheimer's disease: The cerebrovascular link","volume":"28","author":"Ramos-Cejudo","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib133","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of abeta clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib134","doi-asserted-by":"crossref","first-page":"707482","DOI":"10.1155\/2012\/707482","article-title":"Tau protein: Function and pathology","volume":"2012","author":"Rosenmann","year":"2012","journal-title":"International Journal of Alzheimer's Disease"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib135","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1523\/JNEUROSCI.1675-13.2014","article-title":"A sensitive abeta oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid","volume":"34","author":"Savage","year":"2014","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib136","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11682-014-9329-5","article-title":"Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer's disease","volume":"9","author":"Schultz","year":"2015","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib137","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib138","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005777","article-title":"Synapses and Alzheimer's disease","volume":"4","author":"Sheng","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"6534","key":"10.1016\/bs.apcsb.2019.08.003_bib139","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"issue":"18","key":"10.1016\/bs.apcsb.2019.08.003_bib140","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib141","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer's disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Current Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336896.2017.1405207","article-title":"Somatostatin in Alzheimer's disease: A new role for an old player","volume":"12","author":"Solarski","year":"2018","journal-title":"Prion"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib143","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.apcsb.2019.08.003_bib144","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1074\/jbc.270.7.3063","article-title":"The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation","volume":"270","author":"Soto","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12031-011-9566-7","article-title":"Are tangles as toxic as they look?","volume":"45","author":"Spires-Jones","year":"2011","journal-title":"Journal of Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib146","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1097\/HTR.0000000000000325","article-title":"The role of cognitive reserve in recovery from traumatic brain injury","volume":"33","author":"Steward","year":"2018","journal-title":"The Journal of Head Trauma Rehabilitation"},{"issue":"Pt 3","key":"10.1016\/bs.apcsb.2019.08.003_bib147","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1042\/BST0350574","article-title":"The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain","volume":"35","author":"Stockley","year":"2007","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib148","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fnagi.2014.00282","article-title":"Nutrition and prevention of Alzheimer's dementia","volume":"6","author":"Swaminathan","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"Suppl. 2","key":"10.1016\/bs.apcsb.2019.08.003_bib149","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/NMM:2:2:151","article-title":"Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease","volume":"2","author":"Terwel","year":"2002","journal-title":"NeuroMolecular Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib151","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","article-title":"Amyloid beta peptide oligomers directly activate NMDA receptors","volume":"49","author":"Texido","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib152","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2164-14-290","article-title":"Origins of amyloid-beta","volume":"14","author":"Tharp","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib153","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","article-title":"Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease","volume":"51","author":"Tracy","year":"2018","journal-title":"Current Opinion in Neurobiology"},{"issue":"12","key":"10.1016\/bs.apcsb.2019.08.003_bib154","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1091\/mbc.6.12.1887","article-title":"Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules","volume":"6","author":"Trinczek","year":"1995","journal-title":"Molecular Biology of the Cell"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib155","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/prot.22705","article-title":"Folding and membrane insertion of amyloid-beta (25-35) peptide and its mutants: Implications for aggregation and neurotoxicity","volume":"78","author":"Tsai","year":"2010","journal-title":"Proteins"},{"issue":"11","key":"10.1016\/bs.apcsb.2019.08.003_bib156","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1523\/JNEUROSCI.20-11-03937.2000","article-title":"The plasmin system is induced by and degrades amyloid-beta aggregates","volume":"20","author":"Tucker","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apcsb.2019.08.003_bib157","doi-asserted-by":"crossref","first-page":"e34376","DOI":"10.1371\/journal.pone.0034376","article-title":"Somatostatin modulates insulin-degrading-enzyme metabolism: Implications for the regulation of microglia activity in AD","volume":"7","author":"Tundo","year":"2012","journal-title":"PLoS One"},{"issue":"50","key":"10.1016\/bs.apcsb.2019.08.003_bib158","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1073\/pnas.0408153101","article-title":"In silico study of amyloid beta-protein folding and oligomerization","volume":"101","author":"Urbanc","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"9","key":"10.1016\/bs.apcsb.2019.08.003_bib159","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.freeradbiomed.2004.02.013","article-title":"Reactive oxygen species induce different cell death mechanisms in cultured neurons","volume":"36","author":"Valencia","year":"2004","journal-title":"Free Radical Biology and Medicine"},{"issue":"20","key":"10.1016\/bs.apcsb.2019.08.003_bib160","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1523\/JNEUROSCI.0527-10.2010","article-title":"Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone-neuronal progenitors via cell-autonomous mechanisms involving notch signaling","volume":"30","author":"Veeraraghavalu","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib161","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.expneurol.2015.05.006","article-title":"Models and mechanisms of vascular dementia","volume":"272","author":"Venkat","year":"2015","journal-title":"Experimental Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib162","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0972-2327.144284","article-title":"Toxic species in amyloid disorders: Oligomers or mature fibrils","volume":"18","author":"Verma","year":"2015","journal-title":"Annals of Indian Academy of Neurology"},{"issue":"35","key":"10.1016\/bs.apcsb.2019.08.003_bib163","doi-asserted-by":"crossref","first-page":"18484","DOI":"10.1074\/jbc.M116.740530","article-title":"Flexibility and solvation of amyloid-beta hydrophobic core","volume":"291","author":"Vugmeyster","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib164","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12264-013-1425-9","article-title":"Environmental factors in the development and progression of late-onset Alzheimer's disease","volume":"30","author":"Wainaina","year":"2014","journal-title":"Neuroscience Bulletin"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ph7050545","article-title":"Human antimicrobial peptides and proteins","volume":"7","author":"Wang","year":"2014","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib166","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"European Journal of Neuroscience"},{"issue":"47","key":"10.1016\/bs.apcsb.2019.08.003_bib167","doi-asserted-by":"crossref","first-page":"39834","DOI":"10.1074\/jbc.M112.371641","article-title":"Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein","volume":"287","author":"Wang","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2019.08.003_bib168","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer's disease: An updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib169","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/bs.apcsb.2019.08.003_bib170","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib171","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11064-018-2511-1","article-title":"Dysfunctional gamma-secretase in familial Alzheimer's disease","volume":"44","author":"Wolfe","year":"2019","journal-title":"Neurochemical Research"},{"issue":"8","key":"10.1016\/bs.apcsb.2019.08.003_bib172","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.bbalip.2010.05.009","article-title":"Cholesterol-related genes in Alzheimer's disease","volume":"1801","author":"Wollmer","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"5","key":"10.1016\/bs.apcsb.2019.08.003_bib173","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","article-title":"Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease","volume":"85","author":"Xia","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib174","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2007.10.005","article-title":"Cholesterol retention in Alzheimer's brain is responsible for high beta- and\u00a0gamma-secretase activities and Abeta production","volume":"29","author":"Xiong","year":"2008","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2019.08.003_bib175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer's disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib176","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","article-title":"Mechanisms of amyloid-beta peptide clearance: Potential therapeutic targets for Alzheimer's disease","volume":"20","author":"Yoon","year":"2012","journal-title":"Biomolecules & Therapeutics"},{"issue":"Suppl. 1","key":"10.1016\/bs.apcsb.2019.08.003_bib177","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.archger.2009.09.035","article-title":"Life expectancy in Alzheimer's disease (AD)","volume":"49","author":"Zanetti","year":"2009","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"3","key":"10.1016\/bs.apcsb.2019.08.003_bib178","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/1055-8330(95)90018-7","article-title":"Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly","volume":"4","author":"Zhan","year":"1995","journal-title":"Neurodegeneration"},{"issue":"6","key":"10.1016\/bs.apcsb.2019.08.003_bib179","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.3390\/ijms13067303","article-title":"The toxicity of amyloid beta oligomers","volume":"13","author":"Zhao","year":"2012","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Protein Misfolding"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162319300574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162319300574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:18:33Z","timestamp":1761754713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162319300574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128177501"],"references-count":179,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2019.08.003","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}